Holen Sie sich die Stockscreener-App
0.00
100.00%
-5.34
Schlusskurs vom Vortag:
$5.34
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$35.98M
Einnahmen:
$15.27M
Nettoeinkommen (Verlust:
$-62.63M
KGV:
0.00
EPS:
-7.3629
Netto-Cashflow:
$-114.74M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$6.95
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Compare GBIO vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.00 | 35.98M | 15.27M | -62.63M | -114.74M | -7.3629 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 110.47B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.67B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.53B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 43.81B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.36B | 606.42M | -1.28B | -997.58M | -6.403 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-12-16 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-08-13 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN
Generation Bio Co stock: Why this gene therapy innovator merits your watchlist now - AD HOC NEWS
XOMA SEC FilingsXOMA Royalty Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Report: Whats the beta of Generation Bio Co stock2026 Geopolitical Influence & AI Driven Price Forecasts - baoquankhu1.vn
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
If You Invested $1,000 in Generation Bio Co. (GBIO) - Stock Titan
Wedbush Downgrades Generation Bio (GBIO) - MSN
Aug Spikes: Whats the beta of Generation Bio Co stockWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Jefferies downgrades Generation Bio (GBIO) - MSN
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates - Businesskorea
Will Generation Bio Co benefit from green energy policiesTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
How interest rate cuts could boost Generation Bio Co. stockDividend Hike & AI Based Trade Execution Alerts - Naître et grandir
Performance Recap: Can Generation Bio Co grow without external fundingMarket Growth Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Generation Bio (GBIO) to Release Earnings on Thursday - Defense World
Sironix Renewables Launches Furasoft™Next Generation, Bio-Based Surfactant for Personal Care - The Manila Times
Generation Bio Co. (NASDAQ:GBIO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
GBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MegazoneCloud to work with CellKey AI on global business for bio AI solutions - 디지털투데이
[15-12G] Generation Bio Co. SEC Filing - Stock Titan
T. Rowe Price holds 3.1% of Generation Bio (GBIO) shares - Stock Titan
Will Generation Bio Co. benefit from green energy policiesJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - mfd.ru
Generation Bio (NASDAQ:GBIO) Stock Rating Upgraded by Wall Street Zen - Defense World
Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com Australia
Bear Alert: Why is Generation Bio Co. stock going downJuly 2025 Analyst Calls & Stock Portfolio Risk Management - mfd.ru
Why Generation Bio Co. stock remains undervaluedWeekly Gains Summary & Fast Moving Stock Watchlists - mfd.ru
Baselake exits Generation Bio (NASDAQ: GBIO) reporting 0% ownership stake - Stock Titan
New Highs: What drives Generation Bio Co.’s stock priceShort Setup & Weekly Sector Rotation Insights - mfd.ru
Generation Bio pays landlord $21.5M to escape lease early after Xoma buyout - The Business Journals
Biotech Firm Terminates Cambridge Headquarters Lease Early - Connect CRE
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share By Investing.com - Investing.com South Africa
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Generation Bio; GBIO delisted from Nasdaq - Investing.com
XOMA Completes Acquisition and Delisting of Generation Bio - TipRanks
XOMA Royalty Completes Generation Bio Acquisition and Merger - TipRanks
Generation Bio Announced Transfer or Voluntary Withdrawal of Listing - TradingView
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - The Manila Times
XOMA Royalty Corporation Completes Acquisition of Generation Bio Co. Through Tender Offer - Quiver Quantitative
Generation Bio investors cashed out at $4.2913 a share in XOMA takeover - Stock Titan
Wilson Disease Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Deep Genomics Inc, DepYmed Inc, Enveda Biosciences Inc, Generation Bio Co, Vivet Therapeutics - Barchart.com
Generation Bio Co. (NASDAQ:GBIO) Given Average Rating of “Hold” by Brokerages - Defense World
Buyout Rumor: How correlated is SQFTW to the S P5002025 Key Highlights & Community Consensus Trade Alerts - baoquankhu1.vn
Satellos Bioscience Welcomes New Chief Development Officer - GuruFocus
Satellos taps ex-Generation Bio COO to steer Duchenne trial plans - stocktitan.net
Returns Recap: How liquid is NCC.PRBC stockIPO Watch & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Why is Generation Bio Co stock going down2025 AllTime Highs & Smart Investment Allocation Insights - baoquankhu1.vn
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Halper Sadeh Investigates Shareholder Rights Violations at Diamond Hill, Generation Bio, and Contango - Intellectia AI
Investor Mood: Is Generation Bio Co a defensive stockTrade Entry Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Gap Down: Whats next for Generation Bio Co stockBreakout Watch & Long-Term Growth Plans - baoquankhu1.vn
Profit Review: Is Gen Digital Inc. in a long term uptrendEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Hedge Fund Moves: Is Generation Bio Co benefiting from innovation trendsWeekly Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):